We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Guidance will be key from both companies, a theme we'll see in the Q1 reporting cycle.
Both stocks have showed great relative strength in 2025.
Earnings season is always exciting for investors, with companies finally pulling the curtain back and unveiling what’s happened behind the scenes. Guidance is notably more critical this reporting cycle, given the recent tariff-induced spooks that we’ve become accustomed to.
Importantly, several notable large-cap stocks are reporting this week, a list that includes Progressive (PGR - Free Report) and UnitedHealth (UNH - Free Report) . As shown below, PGR and UNH shares have shown great relative strength in 2025.
Image Source: Zacks Investment Research
Let’s take a closer look at what to expect from each.
UNH Expectations Remain Stable
UnitedHealth Group offers a full spectrum of health benefits, with its Optum segment using data and technology to improve care delivery and health outcomes.
UNH is currently a Zacks Rank #2 (Buy), with the earnings estimate revisions trend for its upcoming release largely stable over recent months. Top line revisions have also primarily remained stable, with the company expected to see 5% EPS growth on 11% higher sales.
Image Source: Zacks Investment Research
Shares presently trade at a 19.5X forward 12-month earnings multiple, in line with the five-year median and beneath a 26.6X five-year high. The current PEG ratio works out to 1.6X, above the 1.4X five-year median and off modestly from 1.9X five-year highs.
Image Source: Zacks Investment Research
PGR Outlook Stays Bullish
Progressive is one of the largest auto and property insurers in the U.S., known for its direct-to-consumer model and strong underwriting performance. The company offers various insurance products, including auto, home, renters, and commercial lines.
The stock is currently a Zacks Rank #2 (Buy), with earnings expectations moving higher across the board. As shown below, the revisions trend for the upcoming print has been notably bullish, up 27% over the last 60 days.
Image Source: Zacks Investment Research
Revenue revisions have remained stagnant, with PGR expected to see a big 27% year-over-year increase in EPS on nearly 20% higher sales. The company has been a star earnings performer overall, exceeding the Zacks Consensus EPS estimate by an average of 18% across its last four releases.
Shares presently trade at a 17.6X forward 12-month earnings multiple, which compares to a 19.3X five-year median and 31.9X five-year highs. The stock sports a Style Score of ‘C’ for Value.
Image Source: Zacks Investment Research
Bottom Line
The 2025 Q1 earnings season picks up considerably this week, with large-cap companies Progressive (PGR - Free Report) and UnitedHealth (UNH - Free Report) partly headlining the reporting docket.
Guidance will be key from both companies, but it’s worth mentioning that both companies are largely insulated from tariff worries thanks to their domestic operations, reflecting a key differentiator in today’s political climate.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Key Large Cap Reports to Watch This Week
Key Takeaways
Earnings season is always exciting for investors, with companies finally pulling the curtain back and unveiling what’s happened behind the scenes. Guidance is notably more critical this reporting cycle, given the recent tariff-induced spooks that we’ve become accustomed to.
Importantly, several notable large-cap stocks are reporting this week, a list that includes Progressive (PGR - Free Report) and UnitedHealth (UNH - Free Report) . As shown below, PGR and UNH shares have shown great relative strength in 2025.
Image Source: Zacks Investment Research
Let’s take a closer look at what to expect from each.
UNH Expectations Remain Stable
UnitedHealth Group offers a full spectrum of health benefits, with its Optum segment using data and technology to improve care delivery and health outcomes.
UNH is currently a Zacks Rank #2 (Buy), with the earnings estimate revisions trend for its upcoming release largely stable over recent months. Top line revisions have also primarily remained stable, with the company expected to see 5% EPS growth on 11% higher sales.
Image Source: Zacks Investment Research
Shares presently trade at a 19.5X forward 12-month earnings multiple, in line with the five-year median and beneath a 26.6X five-year high. The current PEG ratio works out to 1.6X, above the 1.4X five-year median and off modestly from 1.9X five-year highs.
Image Source: Zacks Investment Research
PGR Outlook Stays Bullish
Progressive is one of the largest auto and property insurers in the U.S., known for its direct-to-consumer model and strong underwriting performance. The company offers various insurance products, including auto, home, renters, and commercial lines.
The stock is currently a Zacks Rank #2 (Buy), with earnings expectations moving higher across the board. As shown below, the revisions trend for the upcoming print has been notably bullish, up 27% over the last 60 days.
Image Source: Zacks Investment Research
Revenue revisions have remained stagnant, with PGR expected to see a big 27% year-over-year increase in EPS on nearly 20% higher sales. The company has been a star earnings performer overall, exceeding the Zacks Consensus EPS estimate by an average of 18% across its last four releases.
Shares presently trade at a 17.6X forward 12-month earnings multiple, which compares to a 19.3X five-year median and 31.9X five-year highs. The stock sports a Style Score of ‘C’ for Value.
Image Source: Zacks Investment Research
Bottom Line
The 2025 Q1 earnings season picks up considerably this week, with large-cap companies Progressive (PGR - Free Report) and UnitedHealth (UNH - Free Report) partly headlining the reporting docket.
Guidance will be key from both companies, but it’s worth mentioning that both companies are largely insulated from tariff worries thanks to their domestic operations, reflecting a key differentiator in today’s political climate.